FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118538055> ?p ?o ?g. }

• W3118538055 abstract "Abstract Background Cardiovascular disease (CVD) is the most common complication and the leading cause of death in patients with chronic kidney disease (CKD). Accelerated atherosclerosis is a pathophysiological process that is vital to the occurrence of cardiovascular complications associated with CKD. Abnormal platelet activation is not only the leading cause of atherosclerosis but also plays a critical role in the occurrence of thrombotic events. Currently, antiplatelet drugs are commonly used as a secondary prevention strategy for high blood pressure, obesity, diabetes, and ischemic heart disease and can reduce the risk of CVD in the susceptible population. However, the benefits and evidence of using antiplatelet agents in patients with CKD remain controversial. This study aimed to determine whether antiplatelet therapy can safely prevent atherosclerosis in patients with CKD in the primary care setting. Methods/design The ALTAS-CKD study is a multicenter, prospective, randomized, double-blind, placebo-controlled trial of 554 adult patients with stage 3–5 non-dialysis-dependent CKD recruited from 10 territory medical centers in China. A secured web-based computer randomization system will be used to administer aspirin 100 mg once daily or a matching inactive placebo for 36 months. The primary endpoint will be the occurrence of atherosclerosis, as measured by carotid ultrasonography. The secondary endpoints will be combined cardiovascular events, all-cause mortality, and 50% decrease in the estimated glomerular filtration rate. Trial registration {2a} Current controlled trials number: ChiCTR1900021393 . Registered on 18 February 2019." @default.
• W3118538055 created "2021-01-18" @default.
• W3118538055 creator A5002557721 @default.
• W3118538055 creator A5016199726 @default.
• W3118538055 creator A5021979312 @default.
• W3118538055 creator A5026228415 @default.
• W3118538055 creator A5029629091 @default.
• W3118538055 creator A5036135848 @default.
• W3118538055 creator A5061099118 @default.
• W3118538055 creator A5061601801 @default.
• W3118538055 creator A5066893106 @default.
• W3118538055 creator A5081303856 @default.
• W3118538055 creator A5084751257 @default.
• W3118538055 creator A5091081476 @default.
• W3118538055 date "2021-01-07" @default.
• W3118538055 modified "2023-10-16" @default.
• W3118538055 title "Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial" @default.
• W3118538055 cites W2049340875 @default.
• W3118538055 cites W2050820265 @default.
• W3118538055 cites W2059609157 @default.
• W3118538055 cites W2076272135 @default.
• W3118538055 cites W2091092840 @default.
• W3118538055 cites W2120309176 @default.
• W3118538055 cites W2125575764 @default.
• W3118538055 cites W2128315097 @default.
• W3118538055 cites W2129837832 @default.
• W3118538055 cites W2130643758 @default.
• W3118538055 cites W2157148867 @default.
• W3118538055 cites W2258527395 @default.
• W3118538055 cites W2337136207 @default.
• W3118538055 cites W2413852431 @default.
• W3118538055 cites W2474699632 @default.
• W3118538055 cites W2484042144 @default.
• W3118538055 cites W2495583055 @default.
• W3118538055 cites W2550051895 @default.
• W3118538055 cites W2591723566 @default.
• W3118538055 cites W2603645732 @default.
• W3118538055 cites W2614395686 @default.
• W3118538055 cites W2782423901 @default.
• W3118538055 cites W2784395700 @default.
• W3118538055 cites W2802878221 @default.
• W3118538055 cites W2809779924 @default.
• W3118538055 cites W2884597935 @default.
• W3118538055 cites W2898569057 @default.
• W3118538055 cites W2910903021 @default.
• W3118538055 cites W4229508150 @default.
• W3118538055 doi "https://doi.org/10.1186/s13063-020-04992-x" @default.
• W3118538055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7792066" @default.
• W3118538055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33413594" @default.
• W3118538055 hasPublicationYear "2021" @default.
• W3118538055 type Work @default.
• W3118538055 sameAs 3118538055 @default.
• W3118538055 citedByCount "3" @default.
• W3118538055 countsByYear W31185380552022 @default.
• W3118538055 countsByYear W31185380552023 @default.
• W3118538055 crossrefType "journal-article" @default.
• W3118538055 hasAuthorship W3118538055A5002557721 @default.
• W3118538055 hasAuthorship W3118538055A5016199726 @default.
• W3118538055 hasAuthorship W3118538055A5021979312 @default.
• W3118538055 hasAuthorship W3118538055A5026228415 @default.
• W3118538055 hasAuthorship W3118538055A5029629091 @default.
• W3118538055 hasAuthorship W3118538055A5036135848 @default.
• W3118538055 hasAuthorship W3118538055A5061099118 @default.
• W3118538055 hasAuthorship W3118538055A5061601801 @default.
• W3118538055 hasAuthorship W3118538055A5066893106 @default.
• W3118538055 hasAuthorship W3118538055A5081303856 @default.
• W3118538055 hasAuthorship W3118538055A5084751257 @default.
• W3118538055 hasAuthorship W3118538055A5091081476 @default.
• W3118538055 hasBestOaLocation W31185380551 @default.
• W3118538055 hasConcept C126322002 @default.
• W3118538055 hasConcept C134018914 @default.
• W3118538055 hasConcept C142724271 @default.
• W3118538055 hasConcept C164705383 @default.
• W3118538055 hasConcept C168563851 @default.
• W3118538055 hasConcept C177713679 @default.
• W3118538055 hasConcept C203092338 @default.
• W3118538055 hasConcept C204787440 @default.
• W3118538055 hasConcept C27081682 @default.
• W3118538055 hasConcept C2777628954 @default.
• W3118538055 hasConcept C2778653478 @default.
• W3118538055 hasConcept C2779134260 @default.
• W3118538055 hasConcept C2779541074 @default.
• W3118538055 hasConcept C2779978075 @default.
• W3118538055 hasConcept C2908647359 @default.
• W3118538055 hasConcept C535046627 @default.
• W3118538055 hasConcept C555293320 @default.
• W3118538055 hasConcept C71924100 @default.
• W3118538055 hasConcept C99454951 @default.
• W3118538055 hasConceptScore W3118538055C126322002 @default.
• W3118538055 hasConceptScore W3118538055C134018914 @default.
• W3118538055 hasConceptScore W3118538055C142724271 @default.
• W3118538055 hasConceptScore W3118538055C164705383 @default.
• W3118538055 hasConceptScore W3118538055C168563851 @default.
• W3118538055 hasConceptScore W3118538055C177713679 @default.
• W3118538055 hasConceptScore W3118538055C203092338 @default.
• W3118538055 hasConceptScore W3118538055C204787440 @default.
• W3118538055 hasConceptScore W3118538055C27081682 @default.
• W3118538055 hasConceptScore W3118538055C2777628954 @default.
• W3118538055 hasConceptScore W3118538055C2778653478 @default.
• W3118538055 hasConceptScore W3118538055C2779134260 @default.

• next